These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1188 related items for PubMed ID: 28837221

  • 1. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
    Petsky HL, Li A, Chang AB.
    Cochrane Database Syst Rev; 2017 Aug 24; 8(8):CD005603. PubMed ID: 28837221
    [Abstract] [Full Text] [Related]

  • 2. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
    Petsky HL, Kynaston JA, Turner C, Li AM, Cates CJ, Lasserson TJ, Chang AB.
    Cochrane Database Syst Rev; 2007 Apr 18; (2):CD005603. PubMed ID: 17443604
    [Abstract] [Full Text] [Related]

  • 3. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils).
    Petsky HL, Cates CJ, Lasserson TJ, Li AM, Turner C, Kynaston JA, Chang AB.
    Thorax; 2012 Mar 18; 67(3):199-208. PubMed ID: 20937641
    [Abstract] [Full Text] [Related]

  • 4. Exhaled nitric oxide levels to guide treatment for children with asthma.
    Petsky HL, Kew KM, Chang AB.
    Cochrane Database Syst Rev; 2016 Nov 09; 11(11):CD011439. PubMed ID: 27825189
    [Abstract] [Full Text] [Related]

  • 5. Exhaled nitric oxide levels to guide treatment for adults with asthma.
    Petsky HL, Kew KM, Turner C, Chang AB.
    Cochrane Database Syst Rev; 2016 Sep 01; 9(9):CD011440. PubMed ID: 27580628
    [Abstract] [Full Text] [Related]

  • 6. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
    Petsky HL, Cates CJ, Li A, Kynaston JA, Turner C, Chang AB.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD006340. PubMed ID: 19821360
    [Abstract] [Full Text] [Related]

  • 7. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.
    Kew KM, Flemyng E, Quon BS, Leung C.
    Cochrane Database Syst Rev; 2022 Sep 26; 9(9):CD007524. PubMed ID: 36161875
    [Abstract] [Full Text] [Related]

  • 8. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
    Petsky HL, Cates CJ, Li AM, Kynaston JA, Turner C, Chang AB.
    Cochrane Database Syst Rev; 2008 Apr 16; (2):CD006340. PubMed ID: 18425949
    [Abstract] [Full Text] [Related]

  • 9. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.
    Chauhan BF, Jeyaraman MM, Singh Mann A, Lys J, Abou-Setta AM, Zarychanski R, Ducharme FM.
    Cochrane Database Syst Rev; 2017 Mar 16; 3(3):CD010347. PubMed ID: 28301050
    [Abstract] [Full Text] [Related]

  • 10. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.
    Kew KM, Quinn M, Quon BS, Ducharme FM.
    Cochrane Database Syst Rev; 2016 Jun 07; 2016(6):CD007524. PubMed ID: 27272563
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D for the management of asthma.
    Williamson A, Martineau AR, Sheikh A, Jolliffe D, Griffiths CJ.
    Cochrane Database Syst Rev; 2023 Feb 06; 2(2):CD011511. PubMed ID: 36744416
    [Abstract] [Full Text] [Related]

  • 12. Omalizumab for asthma in adults and children.
    Normansell R, Walker S, Milan SJ, Walters EH, Nair P.
    Cochrane Database Syst Rev; 2014 Jan 13; 2014(1):CD003559. PubMed ID: 24414989
    [Abstract] [Full Text] [Related]

  • 13. Interventions to improve adherence to inhaled steroids for asthma.
    Normansell R, Kew KM, Stovold E.
    Cochrane Database Syst Rev; 2017 Apr 18; 4(4):CD012226. PubMed ID: 28417456
    [Abstract] [Full Text] [Related]

  • 14. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF, Chartrand C, Ducharme FM.
    Cochrane Database Syst Rev; 2013 Feb 28; (2):CD009611. PubMed ID: 23450606
    [Abstract] [Full Text] [Related]

  • 15. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Chauhan BF, Ducharme FM.
    Cochrane Database Syst Rev; 2014 Jan 24; 2014(1):CD003137. PubMed ID: 24459050
    [Abstract] [Full Text] [Related]

  • 16. Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults.
    Chong J, Haran C, Chauhan BF, Asher I.
    Cochrane Database Syst Rev; 2015 Jul 22; 2015(7):CD011032. PubMed ID: 26197430
    [Abstract] [Full Text] [Related]

  • 17. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF, Chartrand C, Ducharme FM.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD009611. PubMed ID: 23235678
    [Abstract] [Full Text] [Related]

  • 18. Macrolides versus placebo for chronic asthma.
    Undela K, Goldsmith L, Kew KM, Ferrara G.
    Cochrane Database Syst Rev; 2021 Nov 22; 11(11):CD002997. PubMed ID: 34807989
    [Abstract] [Full Text] [Related]

  • 19. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005535. PubMed ID: 16235410
    [Abstract] [Full Text] [Related]

  • 20. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T, Milan SJ, Wang R, Banchoff E, Bradley P, Crossingham I.
    Cochrane Database Syst Rev; 2020 Dec 08; 12(12):CD013432. PubMed ID: 33295032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.